Name
OSAÜHING PEREARST BERS-KURBAT
Registry code
10970389
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.09.2003 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
179 932 €
-7 973 €
-4%
-
2 556 €
0
Submitted
No tax arrears
-312%
-312%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Galina Bers 20.08.1944 (80) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 25.02.2020 | 2020 23.03.2021 | 2021 22.03.2022 | 2022 22.02.2023 | 2023 30.01.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 219 964 € | 246 744 € | 279 841 € | 323 832 € | 179 932 € |
| Net profit (loss) for the period | 21 124 € | 28 411 € | -18 190 € | 5 045 € | -7 973 € |
| Profit Margin | 10% | 12% | -7% | 2% | -4% |
| Current Assets | 22 779 € | 33 450 € | 20 589 € | 31 477 € | 2 556 € |
| Fixed Assets | 24 267 € | 15 328 € | 11 497 € | 3 835 € | 0 € |
| Total Assets | 47 046 € | 48 778 € | 32 086 € | 35 312 € | 2 556 € |
| Current Liabilities | 20 795 € | 25 104 € | 26 602 € | 24 783 € | 0 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 26 251 € | 23 674 € | 5 484 € | 10 529 € | 2 556 € |
| Employees | 4 | 4 | 4 | 3 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2023 Q3 | - | 23 136.1 € | 20 286.91 € | - |
| 2023 Q2 | - | 23 013.72 € | 20 140.08 € | 4 |
| 2023 Q1 | - | 18 594.2 € | 19 322.03 € | 4 |
| 2022 Q4 | - | 17 831.89 € | 18 571.89 € | 5 |
| 2022 Q3 | - | 20 245.89 € | 18 338.63 € | 5 |
| 2022 Q2 | - | 15 894.4 € | 16 738.8 € | 4 |
| 2022 Q1 | - | 16 240.65 € | 17 190.42 € | 4 |
| 2021 Q4 | - | 19 373.81 € | 17 168.33 € | 4 |
| 2021 Q3 | - | 15 328.4 € | 16 215.63 € | 4 |
| 2021 Q2 | - | 19 577.13 € | 18 152.41 € | 4 |
| 2021 Q1 | - | 17 020.76 € | 14 976.73 € | 5 |
| 2020 Q4 | - | 13 327.32 € | 14 234 € | 4 |
| 2020 Q3 | - | 17 760.1 € | 15 050.87 € | 5 |
| 2020 Q2 | - | 11 848.62 € | 12 587.89 € | 4 |
| 2020 Q1 | - | 11 520.88 € | 12 227.44 € | 4 |
